An experimental study targeting N-methyl-D-aspartate receptor in depression; beyond ketamine
<p>Objective: Despite the availability of vast group of drugs, treatment of depression still remains unsatisfactory. Serious adverse effects of anti-depressants lead to early withdrawal from treatment. One more important concern is the therapeutic lag of nearly 3-4 weeks. Therefore, newer targ...
Sábháilte in:
Príomhchruthaitheoirí: | Salim Sheikh (Údar), Pankaj Sonone (Údar), Chakar Dhar Tripathi (Údar), Veena Verma (Údar), Bushra Ahmed Karim (Údar) |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
Annals of Psychiatry and Treatment - Peertechz Publications,
2020-12-15.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Ketamine; A better anti-depressant? An animal study evaluating the efficacy of citalopram, ketamine and their combination in animal models of depression
de réir: Salim Sheikh, et al.
Foilsithe / Cruthaithe: (2021) -
Comparative evaluation of anti-depressant effects of Citalopram, Ketamine and their combination in animal models of depression: A potential anti-depressant?
de réir: Salim Sheikh, et al.
Foilsithe / Cruthaithe: (2021) -
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (2013) -
Anti-N-Methyl-d-Aspartate Receptor Encephalitis
de réir: Te-Yu Hung, et al.
Foilsithe / Cruthaithe: (2011) -
N-Methyl-D-Aspartate Receptor Antibodies in Herpes Simplex Encephalitis
de réir: J Gordon Millichap
Foilsithe / Cruthaithe: (2013)